LF-FOLFOXNCT07941843
Lactoferrin Supplementation for FOLFOX-Related Toxicities in Colorectal Cancer
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Incidence of Oxaliplatin-Induced Peripheral Neuropathy
Timeframe: From baseline before initiation of FOLFOX therapy to 3 months after initiation of FOLFOX therapy.
Arms and interventions
Standard FOLFOX ChemotherapyActive comparator
Participants assigned to the control group will receive standard FOLFOX chemotherapy consisting of oxaliplatin, 5-fluorouracil, and leucovorin according to the routine oncology treatment protocol.
FOLFOX Plus LactoferrinExperimental
Participants assigned to the intervention group will receive standard FOLFOX chemotherapy plus oral lactoferrin supplementation (Pravotin) at a dose of 100 mg twice daily, initiated at the first chemotherapy cycle and continued throughout the planned chemotherapy course.
Dietary supplements: Lactoferrin
Drugs: FOLFOX chemotherapy regimen